Assessing the risk of Babesia to the United States blood supply using a risk-based decision-making approach: Report of AABB's Ad Hoc Babesia Policy Working Group (original report)

Transfusion

Volumn 58, Issue 8, 2018, Pages 1916-1923

  Ward, Sheila J ^a   Stramer, Susan L ^b   Szczepiorkowski, Zbigniew M ^c  

^a CANADIAN BLOOD SERVICES   (Canada)

^b AMERICAN RED CROSS   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOSOME RNA;

ARTICLE; BABESIA; BABESIA MICROTI; BLOOD SAFETY; CLINICAL DECISION MAKING; COST EFFECTIVENESS ANALYSIS; HEALTH EDUCATION; HEALTH HAZARD; HUMAN; INFECTION PREVENTION; NONHUMAN; PIROPLASMOSIS; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK MANAGEMENT; SCREENING; UNITED STATES; VASCULARIZATION; AWARENESS; DECISION MAKING; DONOR SELECTION; PROCEDURES; STANDARDS;

AWARENESS; BABESIA; BABESIOSIS; BLOOD SAFETY; DECISION MAKING; DONOR SELECTION; HUMANS; RISK ASSESSMENT; UNITED STATES;

EID: 85053034044     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14912     Document Type: Article

References (18)

1. Alliance of Blood Operators [Internet]. 2014 [cited 2018 May 14]. Available from: https://www.allianceofbloodoperators.org/home.aspx
2. Stein J, Besley J, Brook C, et al. Risk-based decision-making for blood safety: preliminary report of a consensus conference. Vox Sang 2011;101:277-81
3. Herwaldt BL, Linden JV, Bosserman E, et al. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011;155:509-19
4. Linden JV, Prusinski MA, Crowder LA, et al. Transfusion-transmitted and community-acquired babesiosis in New York, 2004 to 2015. Transfusion 2018;58:660-8
5. Fatalities reported to FDA following blood collection and transfusion. Annual summary for fiscal year 2014. Silver Spring (MD): U.S. Food and Drug Administration; 2018 [cited 2018 Mar 19]. Available from: http://wayback.archive-it.org/7993/20171114162535/https://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM459461.pdf
6. Moritz ED, Winton CS, Tonnetti L, et al. Screening for Babesia microti in the U.S. blood supply. N Engl J Med 2016;375:2236-45
7. Fang DC, McCullough J. Transfusion-transmitted Babesia microti. Transfus Med Rev 2016;30:132-8
8. Kumar S, Fish D, Krause PJ. Community-acquired and transfusion-transmitted babesiosis are increasing: why and what to do? Transfusion 2018;58:617-9
9. Linden J, Stramer S. Community-acquired and transfusion-transmitted babesiosis are increasing: why and what to do? [Editorial]. Transfusion 2018;58:1818
10. Sher G, Markowitz MA. Babesiosis. AABB Association Bulletin #14-05. Bethesda (MD): AABB; 2014
11. Moritz ED, Tonnetti L, Hewins ME, et al. Description of 15 DNA-positive and antibody-negative "window-period" blood donations identified during prospective screening for Babesia microti. Transfusion 2017;57:1781-6
12. Bish EK, Moritz ED, El-Amine H, et al. Cost-effectiveness of Babesia microti antibody and nucleic acid blood donation screening using results from prospective investigational studies. Transfusion 2015;55:2256-71
13. Goodell AJ, Bloch EM, Krause PJ, et al. Costs, consequences, and cost-effectiveness of strategies for Babesia microti donor screening of the US blood supply. Transfusion 2014;54:2245-57
14. Simon MS, Leff JA, Pandya A, et al. Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. Transfusion 2014;54:889-99
15. Whitaker BI, Rajbhandary S, Harris A. The 2013 AABB blood colletion, utilization, and patient blood management survey report [Internet]. Bethesda (MD): AABB; 2015 [cited 2018 Mar 19]. Available from: http://www.aabb.org/research/hemovigilance/bloodsurvey/Documents/2013-AABB-Blood-Survey-Report.pdf
16. Levin AE, Williamson PC, Bloch EM, et al. Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay. Transfusion 2016;56:1866-74
17. Moritz ED, Stramer SL. Blood donation screening for Babesia microti: feasibility and results. ISBT Sci Ser 2015;10:169-72
18. FDA approves first tests to screen for tickborne parasite in whole blood and plasma to protect the U.S. blood supply. FDA News Release March 6, 2018 [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2018 [cited 2018 Mar 19]. Available from: https://www.prnewswire.com/news-releases/fda-approves-first-tests-to-screen-for-tickborne-parasite-in-whole-blood-and-plasma-to-protect-the-us-blood-supply-300609489.html